Litcius/Paper detail

Safety and efficacy of cerliponase alfa in children with neuronal ceroid lipofuscinosis type 2 (CLN2 disease): an open-label extension study

Angela Schulz, Nicola Specchio, Emily de los Reyes, Paul Gissen, Miriam Nickel, Marina Trivisano, Shawn C. Aylward, Anupam Chakrapani, Christoph Schwering, Eva Wibbeler, Lena Marie Westermann, Douglas Ballon, Jonathan P. Dyke, Anu Cherukuri, Shailesh Bondade, Peter Slasor, Jessica Cohen Pfeffer

2023The Lancet Neurology45 citationsDOIOpen Access PDF

Topics & Concepts

MedicineClinical endpointInternal medicineEnzyme replacement therapyDiseaseAdverse effectPediatricsClinical trialLysosomal Storage Disorders ResearchGlycogen Storage Diseases and MyoclonusGenetic Neurodegenerative Diseases
Safety and efficacy of cerliponase alfa in children with neuronal ceroid lipofuscinosis type 2 (CLN2 disease): an open-label extension study | Litcius